Elevance Health Quarterly Income Statement
NYSE: ELVHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Elevance Health revenue and earnings
In the quarter ended Jun 30, 2026, Elevance Health generated $50.47 billion in revenue, up 1.4% from the same quarter a year earlier. Net income was $1.46 billion (-16.1% year over year), for a net margin of 2.9% versus a median of 3.5% in the prior 5 quarters. Gross margin was 89.1% (down from 89.4%) and operating margin 3.5%.
Diluted earnings per share came in at $6.71, down from $7.72.
Summary generated from market data by MetaCap's automated system. Methodology
Elevance Health income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.47B | 50.18B | 49.75B | 50.71B | 49.78B | 48.89B | 45.44B | 45.11B | 43.89B | 42.58B | 42.65B | 42.85B |
| Revenue growth (YoY) | +1.40% | +2.64% | +9.47% | +12.43% | +13.42% | +14.83% | +6.55% | +5.27% | +0.49% | +0.96% | +6.81% | +7.29% |
| Cost of Revenue | 5.49B | 5.46B | 5.52B | 5.38B | 5.29B | 4.98B | 6.01B | 5.09B | 4.82B | 3.83B | 4.84B | 4.65B |
| Gross Profit | 44.98B | 44.72B | 44.23B | 45.33B | 44.48B | 43.91B | 39.43B | 40.01B | 39.07B | 38.75B | 37.81B | 38.20B |
| Operating Expenses | 48.54B | 47.88B | 49.53B | 49.30B | 47.48B | 46.09B | 44.84B | 43.73B | 40.90B | 39.64B | 41.65B | 41.20B |
| Selling, General & Admin | 5.55B | 6.33B | 5.42B | 5.27B | 5.00B | 5.30B | 4.80B | 5.27B | 5.07B | 4.89B | 5.00B | 5.47B |
| Operating Income | 1.76B | 2.09B | 309.00M | 1.29B | 2.42B | 3.17B | 673.00M | 1.41B | 2.77B | 3.02B | 1.28B | 1.76B |
| Interest Expense | 364.00M | 357.00M | 366.00M | 351.00M | 341.00M | 344.00M | 340.00M | 300.00M | 280.00M | 265.00M | 259.00M | 259.00M |
| Pretax Income | 1.94B | 2.30B | 215.00M | 1.41B | 2.29B | 2.80B | 606.00M | 1.37B | 2.99B | 2.94B | 1.00B | 1.65B |
| Income Tax | 483.00M | 544.00M | -331.00M | 219.00M | 548.00M | 613.00M | 193.00M | 365.00M | 685.00M | 690.00M | 170.00M | 354.00M |
| Net Income | 1.46B | 1.76B | 547.00M | 1.19B | 1.74B | 2.18B | 418.00M | 1.02B | 2.30B | 2.25B | 856.00M | 1.29B |
| Net Income growth (YoY) | -16.06% | -19.19% | +30.86% | +17.03% | -24.22% | -2.80% | -51.17% | -21.18% | +24.12% | +12.92% | -1.04% | -19.59% |
| EPS (Basic) | 6.74 | 8.03 | 2.58 | 5.32 | 7.74 | 9.64 | 1.87 | 4.38 | 9.91 | 9.65 | 3.70 | 5.48 |
| EPS (Diluted) | 6.71 | 8.00 | 2.56 | 5.32 | 7.72 | 9.61 | 1.88 | 4.36 | 9.85 | 9.59 | 3.68 | 5.45 |
| Shares Outstanding (Basic) | 217.00M | 219.80M | — | 223.30M | 225.20M | 226.40M | — | 231.90M | 232.20M | 232.70M | — | 235.30M |
| Shares Outstanding (Diluted) | 217.90M | 220.40M | — | 223.70M | 225.80M | 227.20M | — | 233.10M | 233.40M | 234.20M | — | 236.50M |
| EBITDA | 2.13B | 2.44B | 715.00M | 1.68B | 2.81B | 3.54B | 1.07B | 1.64B | 2.77B | 3.35B | 1.71B | 1.98B |
| Gross Margin | 89.12% | 89.11% | 88.90% | 89.39% | 89.37% | 89.81% | 86.77% | 88.71% | 89.02% | 91.02% | 88.66% | 89.15% |
| Operating Margin | 3.49% | 4.16% | 62.00% | 2.55% | 4.87% | 6.48% | 148.00% | 3.12% | 6.30% | 7.08% | 3.01% | 4.10% |
| Net Margin | 2.90% | 3.52% | 110.00% | 2.34% | 3.50% | 4.47% | 92.00% | 2.25% | 5.24% | 5.28% | 2.01% | 3.01% |
This table shows 12 quarterly periods of Elevance Health's income statement, from Q2 2026 back to Q3 2023, across 18 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ELV's reporting calendar. What is a income statement?